Chemoradiation is a tolerable therapy for older adults with esophageal cancer

Anticancer Research

Volumn 25, Issue 4, 2005, Pages 3055-3060

  Nallapareddy, Sujatha ^a   Wilding, Gregory E ^a   Yang, Gary ^a   Iyer, Renuka ^a   Javle, Milind ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

Aged; Combined modality therapy; Esophageal cancer

Indexed keywords

CISPLATIN; FLUOROURACIL; OXALIPLATIN; PACLITAXEL;

AGED; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GRADING; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CARDIOTOXICITY; CLINICAL ARTICLE; DEHYDRATION; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; DRUG TOLERABILITY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; HYPOTENSION; LUNG TOXICITY; MALE; MUCOSA INFLAMMATION; NEUROPATHY; NEUTROPENIA; PNEUMONIA; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SQUAMOUS CELL; CISPLATIN; COMBINED MODALITY THERAPY; ESOPHAGEAL NEOPLASMS; FEMALE; FLUOROURACIL; HUMANS; MALE; ORGANOPLATINUM COMPOUNDS; PACLITAXEL; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 22944470826     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Devesa SS, Blot WJ and Fraumeni JF Jr: Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 83: 2049-2053, 1998.
2. Poon RT, Law SY, Chu KM, Branicki FJ and Wong J: Esophagectomy for carcinoma of the esophagus in the elderly: results of current surgical management. Ann Surg 227: 357-364, 1998.
3. Lorchel F, Bosset M, Crehange G, Buffet-Miny J, Puyraveau M, Mercier M et al: Chemoradiation for esophageal cancer (EC) in elderly patients over 75 years: a phase II study. ASCO Meeting Abstr 22: 4155, 2004.
4. Yancik R: Epidemiology of cancer in the elderly. Current status and projections for the future. Rays 22: 3-9, 1997.
5. Ginsberg RJ: Cancer treatment in the elderly. J Am Coll Surg 187: 427-428, 1998.
6. Sabel MS, Smith JL, Nava HR, Mollen K, Douglass HO and Gibbs JF: Esophageal resection for carcinoma in patients older than 70 years. Ann Surg Oncol 9: 210-214, 2002.
7. Visbal AL, Allen MS, Miller DL, Deschamps C, Trastek VF and Pairolero PC: Ivor Lewis esophagogastrectomy for esophageal cancer. Ann Thorac Surg 71: 1803-1808, 2001.
8. Collard JM: Exclusive radical surgery for esophageal adenocarcinoma. Cancer 91: 1098-1104, 2001.
9. Iyer R, Wilkinson N, Demmy T and Javle M: Controversies in the multimodality management of locally advanced esophageal cancer: evidence-based review of surgery alone and combined-modality therapy. Ann Surg Oncol 11: 665-673, 2004.
10. Coia LR, Minsky BD, Berkey BA, John MJ, Haller D, Landry J et al: Outcome of patients receiving radiation for cancer of the esophagus: results of the 1992-1994 Patterns of Care Study. J Clin Oncol 18: 455-462, 2000.
11. Herskovic A, Martz K, Al Sarraf M, Leichman L, Brindle J, Vaitkevicius V et al: Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the esophagus. N Engl J Med 326: 1593-1598, 1992.
12. Hurria A and Kris MG: Management of lung cancer in older adults. CA Cancer J Clin 53: 325-341, 2003.
13. Tanisada K, Teshima T, Ikeda H, Abe M, Owen JB, Hanks GE et al: A preliminary outcome analysis of the Patterns of Care Study in Japan for esophageal cancer patients with special reference to age: non surgery group. Int J Radiat Oncol Biol Phys 46: 1223-1233, 2000.
14. Uno T, Isobe K, Kawakami H, Ueno N, Kobayashi H, Shimada H et al: Efficacy and toxicities of concurrent chemoradiation for elderly patients with esophageal cancer. Anticancer Res 24: 2483-2486, 2004.
15. Lorchel F, Bosset M, Crehange G, Buffet-Miny J, Puyraveau M, Mercier M et al: Chemoradiation for esophageal cancer (EC) in elderly patients over 75 years: A phase II study. ASCO Meeting Abstracts 22: 4155, 2004.
16. Pereira JR, Martins SJ, Nikaedo SM and Ikari FK: Chemotherapy with cisplatin and vinorelbine for elderly patients with locally advanced or metastatic non-small-cell lung cancer (NSCLC). BMC Cancer 4: 69, 2004.
17. Siewert JR, Stein HJ, Feith M, Bruecher BL, Bartels H and Fink U: Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann Surg 234: 360-367, 2001.